Healthcare

A judge has dismissed a proceeding against the New South Wales government over a mandate requiring healthcare workers to be vaccinated against COVID-19, saying the applicant’s constitutional case was “legally misconceived and must be rejected.”

Korean drug company Samsung Bioepis has filed a second lawsuit seeking to invalidate German drug company Fresenius Kadi’s patent for a biosimilar of blockbuster arthritis drug Humira.

A former Sigma Healthcare executive has been sentenced to a suspended term of 14 months’ in prison after pleading guilty to trading on insider information.

A class action investigation is underway against Cosmos Clinics Australia after an investigative  report by Fairfax uncovered what it said was a “litany of troubling practices” at its clinics around Australia.

A judge has dismissed a case seeking to force Nine to hand over draft versions of a 60 Minutes episode and related stories, after an appeals court threw out orders that would have forced production of the material.

Nine has won its legal challenge to orders that would have forced it to hand over a draft version of a 60 Minutes episode and restricted it from airing the program after an appeals court found a judge had no power to make the orders.

Regenerative medicine company Mesoblast has been hit with a second class action for allegedly misleading shareholders about it Remestemcel-L treatment for COVID-19 complications.

Philips Electronics has been fined $133,200 for failing to provide timely notice to the country’s health regulator of deterioration in its sleep machines, after being hit with a class action lawsuit over degrading foam in the devices.

Settlement talks in a class action on behalf of women injured by allegedly defective pelvic mesh products have failed after Astora Health took a long-standing $27 million settlement offer off the table. 

The Full Federal Court has rejected an Australian inventor’s appeal of a ruling that found three manufacturers of essential oil products did not infringe his patent because the oil was a “staple commercial product”.